Biolevate raises €30M Series A and opens Boston office for its life sciences AI

The Next Web
Read the full article
Biolevate, a Paris-based AI startup focused on life sciences automation, raised €30M in Series A funding led by Orange Ventures and RAISE France, and opened a Boston office to expand in the US pharmaceutical market. The company’s AI platform accelerates regulatory workflows and is used by over a dozen enterprise clients, including Sanofi and Microsoft.

More in Healthcare

Healthcare2 min read

Google launches $180 Fitbit Edge with a bigger screen and AI coach

The Next Web
Healthcare5 min read

As US medical debt grows, AI will be used more to collect it

The Guardian
Healthcare5 min read

Healthcare AI's Pilot-To-Production Problem

Forbes